Abstract
Background
Endoscopic stenting has demonstrated value over emergent surgery as a palliative intervention for patients with acute large bowel obstruction due to advanced colorectal cancer. However, concerns regarding high reintervention rates and the risk of perforation have brought into question its cost-effectiveness.
Methods
A decision tree analysis was performed to analyze costs and survival in patients with unresectable or metastatic colorectal cancer who present with acute large bowel obstruction. The model was designed with two treatment arms: self-expanding metallic stent (SEMS) placement and emergent surgery. Costs were derived from medicare reimbursement rates (US$), while effectiveness was represented by quality-adjusted life years (QALYs). The primary outcome measure was the incremental cost-effectiveness ratio (ICER). The model was tested for validation using one-way, two-way, and probabilistic sensitivity analyses.
Results
Endoscopic stenting resulted in an average cost of $43,798.06 and 0.68 QALYs. Emergent surgery cost $5865.30 more, while only yielding 0.58 QALYs. This resulted in an ICER of − $58,653.00, indicating that SEMS placement is the dominant strategy. One-way and two-way sensitivity analyses demonstrated that emergent surgery would require an improved survival rate in comparison to endoscopic stenting to become the favored treatment modality. In 100,000 probabilistic simulations, endoscopic stenting was favored 96.3% of the time.
Conclusions
In patients with acute colonic obstruction in the presence of unresectable or metastatic disease, endoscopic stenting is a more cost-effective palliative intervention than emergent surgery. This recommendation would favor surgery over SEMS placement with improved surgical survival, or if the majority of patients undergoing stenting required reintervention.
Similar content being viewed by others
References
American Cancer Society (2019) Cancer facts & figures 2019. American Cancer Society, Atlanta
Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69(1):7–34
Takahashi H, Okabayashi K, Tsuruta M, Hasegawa H, Yahagi M et al (2015) Self-expanding metallic stents versus surgical intervention as palliative therapy for obstructive colorectal cancer: a meta-analysis. World J Surg 39(8):2037–2044
Frago R, Ramirez E, Millan M, Kreisler E, del Valle E et al (2014) Current Management of Acute Malignant Large Bowel Obstruction: A Systematic Review. Am J Surg 207(1):127–138
Biondo S, Pares D, Frago R, Marti-Rague J, Kreisler E et al (2004) Large bowel obstruction: predictive factors for postoperative mortality. Dis Colon Rectum 47(11):1889–1897
Tuca A, Guell E, Martinez-Losada E, Codorniu N (2012) Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution. Cancer Manag Res 4:159–169
Baer C, Menon R, Bastawrous S, Bastawrous A (2017) Emergency presentations of colorectal cancer. Surg Clin North Am 97(3):529–545
Kim EJ, Kim YJ (2016) Stents for colorectal obstruction: past, present, and future. World J Gastroenterol 22(2):842–852
Van Hooft JE, van Halsema EE, Vanbiervliet G, Beets-Tan RG, DeWitt JM et al (2014) Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy 46(11):990–1053
Huang X, Lv V, Zhang S, Meng L (2014) Preoperative colonic stents versus emergency surgery for acute left-sided malignant colonic obstruction: a meta-analysis. J Gastrointest Surg 18(3):584–591
Sagar J (2011) Colorectal stents for the management of malignant colonic obstructions. Cochrane Database Syst Rev 11:CD007378
Thornton JG, Lilford RJ, Johnson N (1992) Decision analysis in medicine. BMJ 304(7023):1099–1103
Young CJ, De-Loyde KJ, Young JM, Solomon MJ, Chew EH et al (2015) Improving quality of life for people with incurable large-bowel obstruction: randomized control trial of colonic stent insertion. Dis Colon Rectum 58(9):838–849
Kobborg M, Broholm M, Frostberg E, Jeppesen M, Gogenur I (2017) Short-term results of self-expanding metal stents for acute malignant large bowel obstruction. Colorectal Dis 19(10):O365–O371
Ahn HJ, Kim SW, Lee SW, Lee SW, Lim CH et al (2016) Long-term outcomes of palliation for unresectable colorectal cancer obstruction in patients with good performance status: endoscopic stent versus surgery. Surg Endosc 30(11):4765–4775
Siddiqui A, Cosgrove N, Yan LH, Brandt D, Janowski R et al (2017) Long-term outcomes of palliative colonic stenting versus emergency surgery for acute proximal malignant colonic obstruction: a multicenter trial. Endosc Int Open 5(4):E232–E238
Ceze N, Charachon A, Locher C, Aparicio T, Mitry E et al (2016) Safety and efficacy in advanced colorectal cancer: a of palliative systemic chemotherapy combined with colorectal self-expandable metallic stents multicenter study. Clin Res Hepatol Gastroenterol 40(2):230–238
Beck JR, Pauker SG, Gottlieb JE, Klein K, Kassirer JP (1982) A convenient approximation of life expectancy (The “DEALE”). II. Use in medical decision making. Am J Med 73(6):889–897
Lee JY, Ock M, Jo MW, Son WS, Lee HJ et al (2017) Estimating utility weights and quality-adjusted life year loss for colorectal cancer-related health states in Korea. Sci Rep 7(1):5571
Riberio IB, Bernardo WM, Martins BDC, de Moura DTH, Baba ER et al (2018) Colonic stent versus emergency surgery as treatment of malignant colonic obstruction in the palliative setting: a systematic review and meta-analysis. Endosc Int Open 6(5):E558–E567
Neumann PJ, Cohen JT, Weinstein MC (2014) Updating cost-effectiveness: the curious resilience of the $50,000-per-QALY threshold. N Engl J Med 371(9):796–797
Fiori E, Lamazza A, Schillaci A, Femia S, Demasi E et al (2012) Palliative management for patients with subacute obstruction and stage IV unresectable rectosigmoid cancer: colostomy versus endoscopic stenting: final results of a prospective randomized trial. Am J Surg 204(3):321–326
Riberio IB, de Moura DTH, Thompson CC, de Moura EGH (2019) Acute abdominal obstruction: colon stent or emergency surgery? An evidence-based review. World J Gastrointest Endosc 11(3):193–208
Van Hooft JE, Fockens P, Marinelli AW, Timmer R, van Berkel AM et al (2008) Early closure of a multicenter randomized clinical trial of endoscopic stenting versus surgery for stage IV left-sided colorectal cancer. Endoscopy 40(3):184–191
Targownik LE, Spiegel BM, Sack J, Hines OJ, Dulai GS et al (2014) Colonic stent vs emergency surgery for management of acute left-sided malignant colonic obstruction: a decision analysis. Gastrointest Endosc 60(6):865–874
Singh H, Latosinsky S, Spiegel BM, Targownik LE (2006) The cost-effectiveness of colonic stenting as a bridge to curative surgery in patients with acute left-sided malignant colonic obstruction: a Canadian perspective. Can J Gastroenterol 20(12):779–785
Xinopoulos D, Dimitroulopoulos D, Theodosopoulos T, Tsamakidis K, Bitsakou G et al (2004) Stenting or stoma creation for patients with inoperable malignant colonic obstructions? Results of a study and cost-effectiveness analysis. Surg Endosc 18(3):421–426
Young CJ, Zahid A (2018) Randomized controlled trial of colonic stent insertion in non-curable large bowel obstruction: a post hoc cost analysis. Colorectal Dis 20(4):288–295
Yoon JY, Jung YS, Hong SP, Kim TI, Kim WH et al (2011) Outcomes of secondary stent-in-stent self-expandable metal stent insertion for malignant colorectal obstruction. Gastrointest Endosc 74(3):625–633
Yoon JY, Park SJ, Hong SP, Kim TI, Kim WH et al (2013) Outcomes of Secondary Self-Expandable Metal Stents Versus Surgery After Delayed Initial Palliative Stent Failure in Malignant Colorectal Obstruction. Digestion 88(1):46–55
Clarke L, Abbott H, Sharma P, Eglinton TW, Frizelle FA (2018) Impact of restenting for recurrent colonic obstruction due to tumour ingrowth. BJS Open 1(6):202–206
Moroi R, Endo K, Ichikawa R, Nagai H, Shinkai H et al (2014) The effectiveness of self-expandable metallic stent insertion in treating right-sided colonic obstruction: a comparison between SEMS and decompression tube placement and an investigation of the safety and difficulties of sems insertion in right colons. Gastroenterol Res Pract 2014:372918
Ji WB, Kwak JM, Kang HD, Um JW, Lee SI et al (2017) Clinical benefits and oncologic equivalence of self-expandable metallic stent insertion for right-sided malignant colonic obstruction. Surg Endosc 31(1):153–158
Van Halsema EE, van Hooft JE, Small AJ, Baron TH, Garcia-Cano J et al (2014) Perforation in colorectal stenting: A meta-analysis and a search for risk factors. Gastrointest Endosc 79(6):970–982
Small AJ, Coelho-Prabhu N, Baron TH (2010) Endoscopic placement of self-expandable metal stents for malignant colonic obstruction: long-term outcomes and complication factors. Gastrointest Endosc 71(3):560–572
Lee JH, Emelogu I, Kukreja K, Ali FS, Nogueras-Gonzalez G et al (2019) Safety and efficacy of metal stents for malignant colonic obstruction in patients treated with bevacizumab. Gastrointest Endosc 90(1):116–124
Author information
Authors and Affiliations
Contributions
All authors contributed to the conception and design, acquisition of data, analysis, and interpretation of data, editing, and final approval. PLQ and SA contributed to the drafting of the article. The revision of the article was performed by SKA and RJC.
Corresponding author
Ethics declarations
Disclosures
Patrick L. Quinn, Simran Arjani, Dr. Sushil K Ahlawat, and Dr. Ravi J. Chokshi have no conflicts of interest or financial ties to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Quinn, P.L., Arjani, S., Ahlawat, S.K. et al. Cost-effectiveness of palliative emergent surgery versus endoscopic stenting for acute malignant colonic obstruction. Surg Endosc 35, 2240–2247 (2021). https://doi.org/10.1007/s00464-020-07637-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-020-07637-x